Baker Brothers Advisors - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$893,298,514
-13.0%
42,864,6120.0%5.15%
-13.3%
Q2 2023$1,026,607,457
+30.1%
42,864,612
+2.2%
5.94%
+38.4%
Q1 2023$789,282,307
+18.3%
41,938,486
+0.0%
4.29%
+7.1%
Q4 2022$667,421,897
-2.7%
41,923,4860.0%4.01%
-10.8%
Q3 2022$685,868,000
+16.1%
41,923,4860.0%4.49%
+34.0%
Q2 2022$590,702,000
-41.8%
41,923,486
+0.0%
3.35%
-42.6%
Q1 2022$1,015,077,000
+3.8%
41,910,7040.0%5.83%
+22.6%
Q4 2021$978,196,000
+40.5%
41,910,7040.0%4.76%
+55.7%
Q3 2021$696,137,000
-31.9%
41,910,7040.0%3.06%
-31.9%
Q2 2021$1,022,202,000
-5.5%
41,910,7040.0%4.49%
-4.2%
Q1 2021$1,081,296,000
-51.7%
41,910,704
+0.0%
4.69%
-44.5%
Q4 2020$2,240,219,000
+29.6%
41,904,5860.0%8.44%
+22.2%
Q3 2020$1,728,564,000
-14.9%
41,904,5860.0%6.91%
-22.9%
Q2 2020$2,031,115,000
+14.7%
41,904,5860.0%8.96%
-17.8%
Q1 2020$1,770,469,000
+1.3%
41,904,586
+2.6%
10.90%
+17.3%
Q4 2019$1,747,759,000
+18.9%
40,854,5860.0%9.29%
-7.1%
Q3 2019$1,470,357,000
+40.0%
40,854,586
+4.0%
10.00%
+40.1%
Q2 2019$1,050,277,000
-1.5%
39,292,086
-1.1%
7.14%
+4.6%
Q1 2019$1,066,317,000
+66.0%
39,713,8420.0%6.83%
+29.8%
Q4 2018$642,173,000
+8.8%
39,713,842
+39.6%
5.26%
+35.2%
Q3 2018$590,396,000
+42.0%
28,439,114
+4.4%
3.89%
+24.5%
Q2 2018$415,777,000
-32.0%
27,228,3380.0%3.12%
-39.8%
Q1 2018$611,821,000
-25.4%
27,228,3380.0%5.19%
-27.0%
Q4 2017$819,845,000
-15.7%
27,228,338
+5.5%
7.11%
-9.9%
Q3 2017$972,631,000
+35.1%
25,819,7680.0%7.89%
+25.3%
Q2 2017$720,113,000
-18.9%
25,819,7680.0%6.30%
-13.3%
Q1 2017$887,684,000
+19.2%
25,819,7680.0%7.26%
-0.5%
Q4 2016$744,642,000
-9.3%
25,819,7680.0%7.30%
-2.1%
Q3 2016$821,327,000
+3.2%
25,819,768
+5.3%
7.45%
-10.7%
Q2 2016$795,813,000
+17.5%
24,516,738
+1.3%
8.34%
+16.9%
Q1 2016$677,019,000
-7.3%
24,213,838
+18.2%
7.14%
+18.0%
Q4 2015$730,163,000
+7.8%
20,481,4420.0%6.05%
-3.3%
Q3 2015$677,321,000
-21.0%
20,481,4420.0%6.26%
-16.8%
Q2 2015$857,763,000
+28.5%
20,481,4420.0%7.52%
+35.5%
Q1 2015$667,490,000
+2.6%
20,481,4420.0%5.55%
-16.3%
Q4 2014$650,286,000
+28.2%
20,481,4420.0%6.64%
+3.9%
Q3 2014$507,121,000
+9.6%
20,481,4420.0%6.39%
+12.7%
Q2 2014$462,676,000
-7.2%
20,481,4420.0%5.67%
-10.5%
Q1 2014$498,313,000
-0.1%
20,481,442
+2.6%
6.33%
-9.9%
Q4 2013$498,679,000
-9.0%
19,955,1260.0%7.03%
-9.8%
Q3 2013$548,167,000
+51.3%
19,955,1260.0%7.79%
+8.8%
Q2 2013$362,186,00019,955,1267.16%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders